Hormone receptor positive breast tumor

A hormone-receptor-positive (HR+) tumor is a tumor which consists of cells that express receptors for certain hormones. The term most commonly refers to estrogen receptor positive estrogen receptor positive tumors  (i.e. tumors that contain estrogen receptor positive cells), but can also include progesterone receptor positive tumors. Estrogen-receptor-positive tumors depend on the presence of estrogen for ongoing proliferation.

 

 

  • Lowering systemic levels of estrogen.
  • Achieved by the use of drugs from the aromatase inhibitor category.
  • Blockage of the estrogen receptors on the cancerous cells
  • Treating hematological malignancies such as lymphoma and leukemia (cancers)
  • The science of blood transfusion and the work of a blood bank

Related Conference of Hormone receptor positive breast tumor

February 04-05, 2026

18th International Conference on Gynecology

Rome, Italy
February 25-26, 2026

15th International Conference on Herbal Medicine and Acupuncture

Aix-en-Provence, France
March 09-10, 2026

13th World Machine Learning and Deep learning Conference

Singapore City, Singapore
March 26-27, 2026

12th World Congress on Anesthesia and Critical Care

Amsterdam, Netherlands
April 20-21, 2026

47th International Summit on Human Anatomy & Physiology

Barcelona, Spain
September 14-15, 2026

6th World Medicine Congress

Rome, Italy
October 19-20, 2026

12th World Congress on Medicinal Plants and Marine Drugs

Aix-en-Provence, France

Hormone receptor positive breast tumor Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in